Erythropoiesis (the process, not a molecule or receptor)

Erythropoiesis is the tightly regulated, multi-step biological process that generates red blood cells (erythrocytes) from stem cells in the bone marrow, ensuring a constant supply for effective oxygen transport. This process is governed by numerous molecular pathways, including cytokine signaling (principally via erythropoietin and its receptor), transcription factors (such as GATA1 and BCL11A), extracellular matrix interactions, and chromatin remodeling complexes that orchestrate gene expression changes required for red cell development and maturation. Diseases of erythropoiesis result in a variety of red cell disorders and are the focus of multiple therapeutic interventions targeting different steps in the pathway.

Other names

Red blood cell productionRBC formationRed cell maturationErythroid development

For drugs acting on erythropoiesis: Receptor agonists (e.g., Erythropoietin receptor agonists) stimulate RBC progenitor proliferation; Enzyme cofactors (e.g., iron) support hemoglobin synthesis; Modulation of transcription factor activity (e.g., BCL11A targeting increases fetal hemoglobin).